DEF: Momentus Seeks Shareholder Approval for Key Capital Raises
Proxy Statement
Momentus Inc. calls a Special Meeting to approve equity issuances for convertible notes, an equity line of credit, inducement warrants, and an increase in authorized Class A common stock.
Summary
- A Special Meeting of Stockholders will be held virtually on January 27, 2026, at 9:00 a.m. Pacific Time.
- The record date for stockholders entitled to vote is December 10, 2025.
- Momentus Inc. effected a 1-for-17.85 reverse stock split on December 17, 2025.
- Stockholders are asked to approve the issuance of Class A common stock related to existing Convertible Notes and Warrants, including potential future exercise price adjustments, to comply with Nasdaq listing rules.
- Approval is sought for the issuance of Class A common stock in connection with the company's Equity Line of Credit (ELOC) and Pre-Funded Warrants, including future ELOC rate adjustments, to comply with Nasdaq listing rules.
- Stockholders will vote on the issuance of Class A common stock for existing October 2025 Inducement Warrants and December 2025 Inducement Warrants, including future exercise price adjustments, to comply with Nasdaq listing rules.
- A proposal to amend the company's Certificate of Incorporation to increase authorized Class A common stock from 250,000,000 shares to 260,000,000 shares requires stockholder approval.
- An Adjournment Proposal is included to permit further solicitation and vote of proxies if insufficient votes are received for other proposals.
- The Board of Directors unanimously recommends voting FOR all proposals.
Sentiment
Score: 4
Explanation: The filing outlines necessary steps for Momentus to secure financing and maintain operational flexibility, which is positive for continuity. However, the significant potential for shareholder dilution across multiple proposals and the explicit mention of risks associated with non-approval (e.g., cash repayments, limited capital access, ongoing expenses for repeated meetings) temper the overall sentiment. It's a critical set of proposals for the company's survival and growth, but comes with substantial shareholder cost.
Positives
- Approval of the Convertible Notes and Warrants Proposal would allow the company to convert approximately $1.5 million in debt to stockholders' equity, increasing the company's equity.
- Approval of the Equity Line of Credit Proposal would enable the company to fully utilize the $50,000,000 maximum commitment amount, providing significant capital for business plans.
- Exercise of the October 2025 Inducement Warrants, if approved, could generate up to approximately $5.8 million in additional proceeds for the company.
- Exercise of the December 2025 Inducement Warrants, if approved, could generate up to approximately $5.6 million in additional proceeds for the company.
- Increasing the authorized shares of Class A common stock provides the company with greater flexibility for future financings, strategic acquisitions, equity compensation, and general corporate purposes without needing immediate further stockholder approval.
Negatives
- Issuance of securities under the Convertible Notes and Warrants Proposal would result in substantial dilution of existing stockholders' percentage ownership.
- There is a possibility that the conversion price of the Convertible Note or exercise price of Investor Warrants may be adjusted lower, leading to an even greater dilutive effect for stockholders.
- The influx of shares from the conversion of Convertible Notes and exercise of Investor Warrants into the public market could have a negative effect on the trading price of Class A common stock.
- If the Equity Line of Credit Proposal is not approved, the company may be limited in the amount of money it can draw down, potentially requiring alternative financing on less advantageous terms or incurring additional transaction expenses.
- The issuance of shares under the ELOC could have an anti-takeover effect by diluting the voting power of a person seeking control of the company.
- If the Inducement Warrant Proposals are not approved, the company is obligated to hold subsequent annual or special meetings every thirty days thereafter to seek stockholder approval, incurring further expense.
Risks
- Existing stockholders will incur substantial dilution of their percentage ownership, voting power, liquidation value, book value per share, and any future earnings per share due to the issuance of Class A common stock under various proposals.
- The influx of shares into the public market from the conversion of Convertible Notes, exercise of Warrants, and utilization of the Equity Line of Credit could depress the market price of Class A common stock.
- If the Equity Line of Credit Proposal is not approved, the company may be unable to fully utilize the ELOC, potentially requiring alternative sources of financing which may not be available on advantageous terms, or at all, and could materially and adversely impact future operating results and business plans.
- Failure to obtain stockholder approval for the Inducement Warrant Proposals will require the company to hold subsequent meetings every thirty days, incurring additional transaction expenses.
- The proposed increase in authorized shares could have an anti-takeover effect by allowing the issuance of additional shares to dilute the stock ownership or voting rights of persons seeking to obtain control or remove current management.
- Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to differ materially from those expressed or implied.
Future Outlook
The company's ability to successfully implement its business plans and ultimately generate value for stockholders is dependent upon its ability to raise capital and satisfy ongoing business needs. The proposed increase in authorized shares aims to provide greater flexibility for future financings, strategic acquisitions, equity compensation, and other general corporate purposes, positioning the company to pursue its objectives and respond to market opportunities in a timely manner.
Management Comments
- The Board unanimously recommends that you vote FOR the Convertible Notes and Warrants Proposal.
- The Board unanimously recommends that you vote FOR the Equity Line of Credit Proposal.
- The Board recommends that you vote FOR the October 2025 Inducement Warrant Proposal.
- The Board recommends that you vote FOR the Share Increase Proposal.
- The Board recommends that you vote FOR the December 2025 Inducement Warrant Proposal.
- The Board recommends that you vote FOR the Adjournment Proposal.
- Our Board is not aware of any matter to be presented for action at the Special Meeting other than the matters referred to above and does not intend to bring any other matters before the Special Meeting.
Industry Context
This filing primarily addresses corporate financing and governance matters specific to Momentus Inc. and its capital structure. The need for capital raises through convertible notes, equity lines of credit, and inducement warrants are common financing strategies for growth-stage companies, particularly in capital-intensive sectors like space technology, to fund operations, research and development, and strategic initiatives. The proposals reflect the company's ongoing efforts to secure funding and maintain financial flexibility within its operational environment.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Amendment to Certificate of Incorporation | Increase the number of authorized shares of Class A common stock from 250,000,000 shares to 260,000,000 shares. | Upon stockholder approval and filing of the Certificate of Amendment with the Secretary of State of Delaware. | Provides greater flexibility for future equity issuances, including financings, acquisitions, and compensation. However, it could have an anti-takeover effect and dilute existing stockholders' ownership and voting rights upon future issuances. |
Stakeholder Impact
- Shareholders: Will experience significant dilution of their percentage ownership, voting power, liquidation value, book value, and economic rights if the equity-related proposals are approved and shares are issued. There is also a potential for a negative impact on the stock price due to increased shares eligible for sale.
- Company (Momentus Inc.): Approval of these proposals is crucial for securing necessary capital, executing its current business plan, and maintaining compliance with Nasdaq listing rules. Non-approval could lead to financial constraints, the need for less favorable alternative financing, and increased expenses from repeated meetings.
- Creditors (Convertible Note holders): If the Convertible Notes and Warrants Proposal is not approved, the company would be required to make cash repayments of the Convertible Note, and the pledged collateral would remain subject to the security interest.
Next Steps
- Stockholders are encouraged to cast their votes online, by phone, or by mail by January 26, 2026, or virtually during the Special Meeting on January 27, 2026.
- The company will announce preliminary voting results at the Special Meeting and publish final results in a Current Report on Form 8-K within four business days after the meeting or when final results are known.
- If the Inducement Warrant Proposals are not approved, the company is obligated to hold subsequent annual or special meetings every thirty days thereafter to seek stockholder approval.
- If the Equity Line of Credit Proposal is not approved, the company may need to seek alternative sources of financing.
Key Dates
| Date | Description |
|---|---|
| March 21, 2025 | Issuance date of March Warrants. |
| April 1, 2025 | Company's latest Annual Report on Form 10-K filed with the SEC. |
| April 9, 2025 | Amendment to the Annual Report on Form 10-K filed with the SEC. |
| July 1, 2025 | Issuance date of July Warrants. |
| August 14, 2025 | Issuance date of Existing August 2025 Warrants. |
| September 25, 2025 | Company entered into a securities purchase agreement with Yield Point NY, LLC and an equity purchase agreement with the Investor. |
| September 29, 2025 | Company filed Current Report on Form 8-K (Investor Form 8-K) detailing Convertible Notes, Warrants, and Equity Line of Credit. |
| October 14, 2025 | Company entered into the October 2025 Inducement Agreement. |
| October 15, 2025 | Company filed Current Report on Form 8-K (October 2025 Inducement Form 8-K) detailing October 2025 Inducement Warrants. |
| October 24, 2025 | Company filed a registration statement on Form S-1 for resale of shares from Convertible Note, Investor Warrants, ELOC, and Commitment Stock. |
| October 27, 2025 | Company filed a registration statement on Form S-1 for resale of October 2025 Inducement Warrant Shares. |
| November 13, 2025 | Investor Resale Registration Statement (for Convertible Note, Investor Warrants, ELOC, Commitment Stock) went effective. |
| November 17, 2025 | Registration statement for October 2025 Inducement Warrant Shares went effective. |
| December 1, 2025 | Date for beneficial ownership calculation of Class A common stock. |
| December 9, 2025 | Company entered into the December 2025 Inducement Agreement. |
| December 10, 2025 | Record date for stockholders entitled to vote at the Special Meeting; Board unanimously adopted resolutions for the Share Increase Proposal. |
| December 12, 2025 | Company filed Current Report on Form 8-K (December 2025 Inducement Form 8-K) detailing December 2025 Inducement Warrants. |
| December 13, 2025 | Deadline for the company to seek stockholder approval for the October 2025 Inducement Warrants. |
| December 17, 2025 | Effective date of the 1-for-17.85 reverse stock split at 5:00 p.m. Eastern Time. |
| December 19, 2025 | Company filed a registration statement on Form S-1 for resale of December 2025 Inducement Warrant Shares. |
| December 23, 2025 | First Amendment to Equity Purchase Agreement (EPA Amendment) was executed. |
| December 29, 2025 | Proxy materials for the Special Meeting were first made available or sent to stockholders. |
| January 26, 2026 | Deadline for submitting votes online, by telephone, or by mail (11:59 p.m. Eastern Time). |
| January 27, 2026 | Special Meeting of Stockholders to be held virtually at 9:00 a.m. Pacific Time. |
| February 7, 2026 | Deadline for the company to seek stockholder approval for the December 2025 Inducement Warrants. |
| September 2026 | Maturity date of the Convertible Note. |
Recommendation
holdThe proposals are essential for Momentus Inc. to secure necessary financing and maintain operational flexibility, which is critical for its ongoing business and Nasdaq listing compliance. While the potential for significant shareholder dilution is a concern, the alternative of not approving these measures could lead to severe financial constraints, the need for less favorable alternative financing, and delays in business plans, which would likely be more detrimental to shareholder value in the long run. Therefore, a 'hold' recommendation acknowledges the necessary but dilutive nature of these actions, emphasizing that they are crucial for the company's continued viability.
Keywords
Momentus Inc., MNTS, SEC filing, proxy statement, special meeting, shareholder vote, Class A common stock, authorized shares, stock split, reverse stock split, convertible notes, warrants, equity line of credit, ELOC, inducement warrants, capital raise, dilution, corporate governance, Nasdaq listing rules, financing, stock issuance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.